Published in Cardiovascular Business Week, July 6th, 2004
This measurement, known as the RNA integrity number (RIN), makes it possible for scientists to objectively measure and communicate the quality of RNA used in experiments, a critical need in the development of advanced therapeutics for cancer and cardiovascular disease.
This limitation has greatly inhibited the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.